Skip to main content
. Author manuscript; available in PMC: 2016 Aug 24.
Published in final edited form as: Int J Hyperthermia. 2013 Oct 21;29(8):845–851. doi: 10.3109/02656736.2013.825014

Table II.

Experimental groups, treatment summary and efficacy.

Treatment description Mice per group Thermal dose? Days to 3× SD Treatment ratio (versus no treatment)
mNP + CDDP + AMF CDDP 1 h before AMF exposure. mNP injected immediately before activation. Treated to CEM60 at centre of tumour 7 Yes 36 2.4 2.6
mNP + AMF mNP injected immediately before activation. Treated to CEM60 at centre of tumour 6 Yes 21 4.5 1.5
CDDP alone CDDP given with no additional treatment/treatment controls 4 No 25 7.1 1.8
CDDP + AMF CDDP 1 h before AMF exposure. PBS injected at the same volume as prescribed mNP for other groups. Thermal probes inserted and exposed to AMF for 30 min 4 No 25 6.3 1.8
CDDP + mNP CDDP 1 h before mNP injection. Animal under anesthesia with body temperature maintained for 30 min after mNP injection 6 No 27 7.0 2.0
AMF PBS injected at the same volume as prescribed mNP for other groups. Thermal probes inserted and exposed to AMF for 30 min 5 No 14 4.0 1.0
No treatment No treatments/treatment controls 6 No 14 4.3 1.0